St. Jude Medical Launches New Trifecta Heart Valve in Japan

Loading...
Loading...
St. Jude Medical, Inc.
STJ
today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare and the launch of the Trifecta™ aortic stented, pericardial tissue valve. The first procedures in Japan were performed at Osaka University Hospital and Saitama Medical University International Medical Center.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsContracts
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...